This is a federal contract award made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $21,927.28, is for the delivery of RUXIENCE 500 MG/50 ML VIAL 50ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of December 13, 2024.
Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor for this award. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp also holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Additionally, the company maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Generated 3/13/25, 10:11 AM